Gut Enterobacteriaceae and uraemic toxins - Perpetrators for ageing.


Journal

Experimental gerontology
ISSN: 1873-6815
Titre abrégé: Exp Gerontol
Pays: England
ID NLM: 0047061

Informations de publication

Date de publication:
03 2023
Historique:
received: 30 11 2022
revised: 11 01 2023
accepted: 12 01 2023
pubmed: 17 1 2023
medline: 25 2 2023
entrez: 16 1 2023
Statut: ppublish

Résumé

Ageing is a complex process that is associated with changes in the composition and functions of gut microbiota. Reduction of gut commensals is the hallmarks of ageing, which favours the expansion of pathogens even in healthy centenarians. Interestingly, gut Enterobacteriaceae have been found to be increased with age and also consistently observed in the patients with metabolic diseases. Thus, they are associated with all-cause mortality, regardless of genetic origin, lifestyle, and fatality rate. Moreover, Enterobacteriaceae are also implicated in accelerating the ageing process through telomere attrition, cellular senescence, inflammasome activation and impairing the functions of mitochondria. However, acceleration of ageing is likely to be determined by intrinsic interactions between Enterobacteriaceae and other associated gut bacteria. Several studies suggested that Enterobacteriaceae possess genes for the synthesis of uraemic toxins. In addition to intestine, Enterobacteriaceae and their toxic metabolites have also been found in other organs, such as adipose tissue and liver and that are implicated in multiorgan dysfunction and age-related diseases. Therefore, targeting Enterobacteriaceae is a nuance approach for reducing inflammaging and enhancing the longevity of older people. This review is intended to highlight the current knowledge of Enterobacteriaceae-mediated acceleration of ageing process.

Identifiants

pubmed: 36646294
pii: S0531-5565(23)00009-8
doi: 10.1016/j.exger.2023.112088
pii:
doi:

Substances chimiques

Uremic Toxins 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112088

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Conflict of interest We authors declare that no competing interests.

Auteurs

Seenivasan Boopathi (S)

Department of Biotechnology, College of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, 603203 Chennai, Tamil Nadu, India. Electronic address: boopaths@srmist.edu.in.

R M Saravana Kumar (RMS)

Department of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 602105, Tamil Nadu, India. Electronic address: saravanakumarrm.sse@saveetha.com.

P Snega Priya (PS)

Department of Biotechnology, College of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, 603203 Chennai, Tamil Nadu, India. Electronic address: sp5830@srmist.edu.in.

B Haridevamuthu (B)

Department of Biotechnology, College of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, 603203 Chennai, Tamil Nadu, India. Electronic address: haridevb@srmist.edu.in.

S P Ramya Ranjan Nayak (SPRR)

Department of Biotechnology, College of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, 603203 Chennai, Tamil Nadu, India.

Laura Chulenbayeva (L)

Laboratory of Human Microbiome and Longevity, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Nur-Sultan 010 000, Kazakhstan. Electronic address: laura.chulenbayeva@nu.edu.kz.

Kushugulova Almagul (K)

Laboratory of Human Microbiome and Longevity, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Nur-Sultan 010 000, Kazakhstan. Electronic address: akushugulova@nu.edu.kz.

Jesu Arockiaraj (J)

Department of Biotechnology, College of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, 603203 Chennai, Tamil Nadu, India. Electronic address: jesuaroa@srmist.edu.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH